What are Islet Cell Tumors ?

Pancreatic Neuroendocrine Tumors, which people usually call Islet Cell Tumors, represent uncommon tumors that develop from the pancreas's hormone-secreting endocrine cells. PNETs develop from unique cells found in the Islets of Langerhans, which exist as endocrine cell clusters distributed throughout the pancreas. The tumors show entirely different growth patterns and clinical behaviors when compared to standard pancreatic cancers. The patients exhibit three different disease patterns, which include slow tumor growth and specific clinical syndromes caused by excessive hormone production, which eventually cause asymptomatic conditions until they are discovered. The tumors exhibit two different biological growth patterns, which include slow growth and aggressive growth, which depend on their grade and stage.

At Tender Palm Super Specialty Hospital in Lucknow, medical professionals from various disciplines work together to treat pancreatic neuroendocrine tumors through a multidisciplinary approach that includes medical oncology, surgical oncology, gastroenterology, endocrinology, radiology, nuclear medicine, and pathology. Medical specialists need accurate diagnostic skills to develop individualized therapy programs that create the best results for patients.

What is the Biological Role of the Pancreas and Islet Cells?

There are two main roles played by the pancreas, including:

• Digestive enzymes that aid in digestion are secreted by the pancreas as part of its exocrine function.
• The pancreas produces hormones through its endocrine function, which regulate glucose metabolism in the body.

The endocrine part of the pancreas contains Islet cells, which consist of:

• Beta cells (produce insulin)
• Alpha cells (produce glucagon)
• Delta cells (produce somatostatin)
• PP cells (produce pancreatic polypeptide)
• G cells (produce gastrin, mainly in the stomach but may occur ectopically)

Endocrine cells give rise to Islet cell tumors. Certain PNETs produce hormones that cause medical conditions by overproducing them.

How are Pancreatic Neuroendocrine Tumors Classified?

The classification system for PNETs divides tumors into two principal categories:

1. Functional Tumors

   The tumors release hormones in higher quantities than normal, which results in identifiable medical syndromes. The following tumors function as endocrine organs:

   1. Insulinoma - Produces excess insulin.
   2. Gastrinoma - Produces excess gastrin.
   3. Glucagonoma - Produces excess glucagon.
   4. VIPoma - Produces vasoactive intestinal peptide.
   5. Somatostatinoma - Produces somatostatin.

   Patients usually discover functional tumors at earlier stages because they experience symptoms linked to hormonal imbalances, which prompt them to seek medical help.

2. Non-Functional Tumors

   The tumors either lack active hormone production or fail to create symptoms that can be detected by medical professionals. The tumors become visible through imaging tests or when they increase in size to produce abdominal pain and intestinal blockage. Patients usually discover non-functional tumors at later stages because they remain unaware of their condition until symptoms appear.

What are the Primary Causes and Risk Factors for PNETs?

Although the precise etiology of PNETs is unknown, a few factors increase the likelihood of developing the disease.

• Individuals suffering from type 1 Multiple Endocrine Neoplasia (MEN1)
• Von Hippel-Lindau-Syndrom
• People with Neurofibromatosis type 1
• People with Tuberous Sclerosis
• People whose families have a history of endocrine tumors

Most cases occur without any genetic conditions that cause the disease.

What are the Symptoms of Functional Islet Cell Tumors?

• Insulinoma: The patient experiences hypoglycemia, resulting in low blood sugar levels. The patient experiences sweating. The patient becomes confused. The patient experiences heart palpitations. The patient experiences episodes of fainting.
• Gastrinoma: The patient develops peptic ulcers that return repeatedly. The patient experiences intense stomach cramps. The patient experiences ongoing diarrhea. The patient experiences acid reflux.
• Glucagonoma: The patient has high blood sugar levels. The patient experiences weight reduction. The patient develops a skin rash that resembles necrolytic migratory erythema.
• VIPoma: The patient experiences severe watery diarrhea. The patient suffers from dehydration. The patient has an electrolyte imbalance, which disrupts bodily functions.

Excessive hormone secretion within each syndrome facilitates earlier identification of these conditions.

What are the Symptoms of Non-Functional Pancreatic Neuroendocrine Tumors?

The tumors produce no active hormones; therefore, the symptoms emerge through tumor development, which leads to:

• Abdominal pain
• Back pain
• Jaundice occurs when the bile duct becomes blocked.
• The patient experiences weight loss without any known cause.
• He or she experiences nausea.
• The patient has a noticeable abdominal lump.

Imaging tests detect these tumors during examinations for various medical conditions.

How are Pancreatic Neuroendocrine Tumors Diagnosed ?

The process requires medical professionals to use laboratory tests, imaging studies, and histopathology to accurately diagnose the disease early.

• Blood Tests:

  • The medical team needs to check specific blood levels based on the suspected tumor type
  • The medical team needs to check insulin and C-peptide levels.
  • The medical team needs to check gastrin levels.
  • The medical team needs to check glucagon levels.
  • The medical team needs to check Chromogranin A levels, which serve as a general marker for neuroendocrine tumors.

• Aging Studies:

  The ability to detect small tumors and metastatic diseases depends on functional imaging.

  • Contrast-enhanced CT scan,
  • Abdominal MRI,
  • Endoscopic ultrasound (EUS),
  • PET-CT uses specialized tracers,such as the DOTATATE scan.

• Biopsy:

  Through endoscopic ultrasound-guided biopsy or surgical excision, medical professionals obtain tissue samples for diagnosis.The medical team assesses tumors based on two criteria:

  The medical team uses grading to assess the level of aggressiveness.

  • The medical team assesses tumors based on the mitotic count.
  • The medical team assesses tumors based on the Ki-67 proliferation index.

What are the stages of Pancreatic Neuroendocrine Tumors ?

Staging evaluates:

• The medical team needs to determine how large the tumor has grown.
• The medical team needs to assess whether the tumor has spread to nearby tissues.
• The medical team needs to check for lymph node involvement.
• The medical team needs to determine whether distant cancer cells have spread to other parts of the body.

The liver serves as the primary site for PNETs to spread throughout the body.

What Treatment Options are available for Pancreatic Neuroendocrine Tumors?

The medical team needs to make treatment decisions taking into account several factors, including the tumor's size, grade, and stage, its functional status, and the patient's overall health.

Surgical Treatment

Surgery represents the main treatment option that can cure localized cancer.

The surgical options include:

In certain cases, surgeons can perform tumor removal operations for liver metastases.

• Enucleation, which involves removing small tumors;
• The surgical procedure of distal pancreatectomy;
• The Whipple procedure, also known as pancreaticoduodenectomy;
• Total pancreatectomy (rare).

Medical Management for Functional Tumors

Hormone-secreting tumors:

Somatostatin analogs reduce hormone synthesis and tumor cell multiplication.

• Proton pump inhibitors - Gastrinoma,
• Insulinoma - glucose regulation,
• Somatostatin analogs - hormone secretion inhibition.

Targeted Therapy

Advances in modern drugs target tumor growth pathways. Some possible pathways include:

Targeted therapy is particularly useful in advanced or metastatic disease.

• mTOR inhibitors,
• Tyrosine kinase inhibitors.

Peptide Receptor Radionuclide Therapy (PRRT)

This is an advanced nuclear medicine therapy that specifically targets cancer cells that express receptors for the radioactive particles used in the treatment. It has shown promising results in controlling metastatic PNETs.

Chemotherapy

This form of treatment is used in high-grade or rapidly growing tumors. It may be recommended for metastatic disease.

Liver-Directed Therapy

For liver metastases:

They decrease the tumor mass and help control symptoms.

• Radiofrequency ablation,
• Transarterial chemoembolization TACE,
• Selective internal radiation therapy.

What is the Prognosis for Pancreatic Neuroendocrine Tumors?

PNETs usually have a better prognosis than pancreatic adenocarcinoma.The prognosis depends on:

High-grade tumors exhibit a more aggressive nature and demand intense treatment.

• Tumor grade,
• Stage of tumor,
• Physical fitness,
• Effectiveness of treatment.

What is Long-Term Follow-Up Strategy for PNETs?

Because PNETs can grow slowly and come back years after initial treatment, close monitoring is important. This includes:

This monitoring may be lifelong

• Imaging studies,
• Hormonal studies,
• Tumor markers.

What are the Complications for Pancreatic Neuroendocrine Tumors?

Potential complications include:

• Hypoglycemia in an insulinoma
• Severe ulcers in a gastrinoma
• Liver failure in metastatic PNET
• Malnutrition
• Diabetes in patients who have had pancreatic surgery

What are the Emotional and Psychological Impacts of Islet Cell Tumors?

A rare tumor diagnosis can cause stress and confusion. The patient will find the following useful:

Because many PNET patients live long-term with their disease, survivorship care is particularly important.

• Counseling,
• Treatment plans,
• Nutrition advice,
• Support from family.

What are the Latest Advances in PNET Management ?

Recent developments: Molecular profiling for personalized therapy, Functional imaging methods have been improved, Advances in PRRT treatment methods, Advances in techniques of minimally invasive surgical procedures, Advances in liver-directed treatment methods. Current research is helping to improve targeted therapy techniques and minimize side effects.

What is the Importance of Early Detection for Pancreatic Neuroendocrine Tumors?

Hormone-related symptoms may be an early indicator of the disease. Appropriate evaluation of patients experiencing recurring episodes of hypoglycemia, chronic ulcers, or diarrhea may be beneficial. Pancreatic masses that are incidentally discovered should be properly evaluated to determine if neuroendocrine tumors are present.

Why choose Tender Palm Super Specialty Hospital for Islet Cell Tumors (Pancreatic Neuroendocrine Tumors) Treatment in Lucknow, India?

Tender Palm Super-Speciality Hospital offers advanced Islet Cell Tumors (Pancreatic Neuroendocrine Tumors) treatment in Lucknow, India, at an affordable cost. We have a team of experienced pancreatic surgeons and endocrinology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including surgical resection, somatostatin analogue therapy, and targeted therapy. Our Pancreatic Surgery and Endocrinology team has decades of experience in successfully treating Islet Cell Tumor in Lucknow, India.

To seek an Expert consultation for Islet Cell Tumors (Pancreatic Neuroendocrine Tumors) Treatment in Lucknow, India:

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back